673 results on '"Wijsenbeek, Marlies"'
Search Results
2. Integrating the assessment of quality of life in care and research in pulmonary fibrosis
3. Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
4. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology
5. Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE
6. Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial
7. Outcomes of lung transplantation in patients with telomere-related forms of progressive fibrosing interstitial lung disease pulmonary fibrosis: A systematic review
8. The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis
9. Increased proportions of circulating PD-1+ CD4+ memory T cells and PD-1+ regulatory T cells associate with good response to prednisone in pulmonary sarcoidosis
10. Idiopathic pulmonary fibrosis
11. Detection of Systemic Sclerosis-Associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology
12. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.
13. Exhaled breath analysis in interstitial lung disease
14. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial
15. Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome
16. Quality of life in sarcoidosis
17. Home monitoring in interstitial lung diseases
18. Pulmonary fibrosis: from pathogenesis to clinical decision-making
19. Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
20. Role of the internet of medical things in care for patients with interstitial lung disease
21. The lung way home: ready for home monitoring in lung diseases?
22. ``It Is a Moving Process": Understanding the Evolution of Explainability Needs of Clinicians in Pulmonary Medicine
23. European Respiratory Society Clinical Practice Guideline on symptom management for adults with serious respiratory illness
24. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
25. Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
26. Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study
27. A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
28. PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough
29. Interstitial lung diseases
30. Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis
31. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry
32. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis
33. Palliative Care in Interstitial Lung Disease
34. Non-organ-specific manifestations of sarcoidosis
35. Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis.
36. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
37. Comprehensive Care of Interstitial Lung Disease
38. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
39. Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study
40. Increased proportions of circulating PD-1+ CD4+ memory T cells and PD-1+ regulatory T cells associate with good response to prednisone in pulmonary sarcoidosis.
41. ERS International Congress 2023: highlights from the Interstitial Lung Diseases Assembly.
42. Educational aspects of rare and orphan lung diseases
43. Pulmonary hemodynamics and transplant‐free survival in sarcoidosis‐associated pulmonary hypertension: Results from an international registry
44. Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
45. Screening for ILD in RA: a survey of 1132 patients with RA
46. Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF)
47. Late Breaking Abstract - Morphine sulfate for the treatment of cough in Idiopathic Pulmonary Fibrosis The PAciFy Cough Randomized Clinical Trial
48. Utility of EXACT®, a patient-reported outcome instrument, for idiopathic pulmonary fibrosis-related cough
49. Effect of BI 1015550, a preferential PDE4B inhibitor, on FEV1/FVC ratio in IPF
50. RA-ILD – new insights into disease burden from an international patient survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.